Identification of specific UGT1A9-mediated glucuronidation of licoricidin in human liver microsomes.


Journal

Biopharmaceutics & drug disposition
ISSN: 1099-081X
Titre abrégé: Biopharm Drug Dispos
Pays: England
ID NLM: 7911226

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 27 04 2018
revised: 29 10 2018
accepted: 16 12 2018
pubmed: 13 1 2019
medline: 15 6 2019
entrez: 13 1 2019
Statut: ppublish

Résumé

Licoricidin is a major prenylated isoflavone of Glycyrrhiza uralensis Fisch. (Leguminosae), and its pharmacological effects have been reported frequently. Typically, flavonoids having multiple hydroxyl groups are unambiguous substrates for glucuronyl conjugation by UDP-glucuronosyltransferases (UGTs). The pharmacological effects of flavonoids are derived from the conjugation of glucuronide to yield the bioactive metabolite. Here, the metabolism of licoricidin in pooled human liver microsomes (HLMs) was investigated using high-resolution quadrupole-orbitrap mass spectrometry. One metabolite (M1) was identified in HLMs after incubation with licoricidin in the presence of uridine 5'-diphosphoglucuronic acid (UDPGA) and NADPH. The structure of M1 was determined as a monoglucuronyl licoricidin, which was selectively produced by UGT1A9. Licoricidin showed a higher metabolic ratio and rapid metabolism with the recombinant human UGT1A9 than mycophenolic acid, a well-known UGT1A9 substrate. In conclusion, the selective formation of 7-glucuronyl licoricidin by UGT1A9 in HLMs could serve as a new selective substrate to determine the activity of UGT1A9 in vitro.

Identifiants

pubmed: 30636046
doi: 10.1002/bdd.2169
doi:

Substances chimiques

Benzopyrans 0
Glucuronides 0
UGT1A9 protein, human 0
licoricidin 929XTD20VK
Glucuronosyltransferase EC 2.4.1.17
UDP-Glucuronosyltransferase 1A9 EC 2.4.1.17

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

94-98

Subventions

Organisme : National Research Foundation of Korea
ID : 2015R1A2A2A01004286
Organisme : Yeungnam University

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Pil Joung Cho (PJ)

BK21 Plus KNU Multi-Omics Based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, 41566, Republic of Korea.

Ju-Hyun Kim (JH)

College of Pharmacy, Yeungnam University, Gyeongsan, 38541, Republic of Korea.

Hye Suk Lee (HS)

BK21 Plus Team for Creative Leader Program for Pharmacomics-based Future, Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, College of Pharmacy, The Catholic University of Korea, Bucheon, 14662, Republic of Korea.

Jeong Ah Kim (JA)

BK21 Plus KNU Multi-Omics Based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, 41566, Republic of Korea.

Sangkyu Lee (S)

BK21 Plus KNU Multi-Omics Based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, 41566, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH